Since the advent of the European Marrow Donor Information System in the first half of the last decade, fully automated data exchange between registry computer systems has been playing an ever-increasing role in the international search for unrelated donors of blood progenitor cells. This exchange, however, was hampered by different local conventions used to present HLA data and complicated by the need to extend the official WHO nomenclature to accommodate the registries' information systems and to cross-validate HLA data obtained with different methods and/or at different loci. The guidelines presented here have been developed by the World Marrow Donor Association to standardize the nomenclature to be used and the validation checks to be applied in the international electronic exchange of HLA-typing data among unrelated volunteer hematopoietic stem cell donor registries and umbilical cord blood banks. Two reference web sites have been designated to maintain and update the approved HLA nomenclature and all the ancillary information needed by the conventions described here.
Introduction
Today, over one-third of patients transplanted with hematopoietic progenitor cells from an unrelated donor receives their cells from a donor in another country. These activities are summarized in the annual report of the World Marrow Donor Association (WMDA), 1 which comprises the data of 60 volunteer donor registries and 40 cord blood banks from around the world for 2004.
The WMDA is a voluntary international organization comprising mainly volunteer donor registries and cord blood banks working together to facilitate and foster this life-saving endeavor encompassing the globe. To this end, the WMDA has established guidelines for the international exchange of hematopoietic progenitor cells 2, 3 and its working groups have developed guidelines on ethical issues related to donation, [4] [5] [6] donor characterization and search algorithms, [7] [8] [9] and the logistics of the search process and progenitor cell transport. 10, 11 Recently, standards for registries engaged in international exchange have been established and an accreditation program was begun in 2003. 12 One goal of the WMDA is to facilitate the exchange of information among donor registries and cord blood banks during international donor searches to ensure the safety and reliability of those exchanges and the timeliness and accuracy of the data provided. (Note, for the remainder of this report, the word 'volunteer' or 'donor' will refer to adult volunteer donors and cord blood units simultaneously. Likewise, the term 'registry' will also refer to cord blood banks.) In most countries, the domestic and international search processes are facilitated by national hub registries connecting the donor and transplant centers and managing a central database and information system. Almost all registries provide 'snapshots' of the HLA phenotypes of their donor files in monthly intervals to the central file of Bone Marrow Donors Worldwide (BMDW), 13 allowing quick identification of registries with potential matches via its online search facility. Most of the larger registries in Europe and America are connected through the European Marrow Donor Information System (EMDIS), an electronic peer-to-peer network allowing not only the retrieval of lists of (potentially) matching donors in the current registry file but also exchanging all kinds of requests and results among the partners in the search process.
The selection of potential donors from a database relies on sophisticated algorithms comparing the patient's HLA type to the HLA types of the donors on the files. Obviously, such algorithms require consistent and 'well-behaved' input data from both donors and patients. The process results in a report listing potentially matched volunteers, which is forwarded to the transplant center caring for the patient.
The transplant center selects a few of these volunteers and performs a more detailed characterization of the HLA assignments (termed 'confirmatory typing') using a fresh blood or DNA sample provided through the national hub registry in the country of the potential donor considered. The HLA assignments of the donor(s) are transmitted back to the hub registry in the donor's country of origin.
HLA types of patients and donors appear in many different formats depending on the typing method and on the resolution of the assay. As the earliest donors on registry databases were recruited over 30 years ago and over 10 million volunteers/units have been recruited since that time, the approaches for HLA typing and assignments have changed considerably over that period. HLA assignments of donors can include serologic broad or split assignments as well as DNA-based results at low-, intermediate-or allele-level resolution. Usually testing includes HLA-A, -B and -DRB1, but additional HLA loci (e.g., HLA-C, -DQB1) may also be defined. Search algorithms must be able to incorporate all of these diverse typing results to select potential HLA matches for each searching patient.
In 2004, registries reported a total 73 476 international search requests received.
1 (This does not reflect the number of patients requiring an international search, since one patient typically will show up in the statistics of several registries.) The informatics issues related to the format in which patients' HLA assignments are received for comparison with the HLA assignments of the donors in the local database are significant, since the search algorithms implemented by each registry may -intentionally or notvary in their behavior. This is particularly true for the less common cases where the international search is even more relevant. Moreover, the HLA assignments of potential donors appearing on a search report must also be understandable to the transplant team residing in the country of the patient. Further exchange of confirmatory typing data with their informatics issues occurs at the rate of over 110 000 requests annually and the data reported back to the donor's registry should be in a form that allows their validation and reintegration into the database without manual intervention. Obviously, this volume of exchange of HLA data makes harmonization of HLA nomenclature a priority for facilitating international donor searches.
The Information Technology and Quality Assurance Working Groups of the WMDA have developed guidelines for the nomenclature of HLA typing assignments to eliminate errors, ambiguities and incompatibilities in the electronic exchange of HLA data between registries to facilitate the operation of the matching algorithms and to speed up the search process. These guidelines are firmly based on the nomenclature developed by the World Health Organization Nomenclature Committee for Factors of the HLA System 14 and uniformly accepted by the HLA community and on the requirements for presenting and condensing HLA data within the format of the registries' information systems. 8 A strategy for the latter has been in use for a long time, but neither specified nor standardized so far. Table 1 describes reference web sites that include relevant information for these guidelines. More information regarding the IMGT/HLA database from which much of this information is taken can be found in Robinson et al. 15 and details concerning the correspondence and conversion between serologic and DNA-based assignments in the HLA Dictionary. 7, 16 The guidelines, shown in detail below for the electronic exchange of HLA data between registries, were approved by the board of the WMDA in 2005. They consist of a set of well-defined rules describing how a valid HLA phenotype and a valid typing result may be presented with regard to the structure and contents of individual data fields and the crosschecks applied between given fields. The guidelines apply to both existing HLA data currently in registry databases as well as assignments obtained in the future. Below, the term 'antigen' refers to an assignment in serological nomenclature obtained with serological methods and the term 'allele' refers to an assignment in DNA nomenclature obtained by DNA-based testing methods.
For the information technology (IT) specialists of registries, these rules can be regarded as the specification of a validation routine to be applied to all incoming HLA data. Such a routine might include review for valid letter codes, basic rules for assignments, and crosschecks between serological and DNA assignments for HLA. An electronically reported phenotype containing invalid codes or violating the basic rules should be rejected by the addressee or at least raise an appropriate warning message for the sender to check their data. All electronic reference materials for these validations can be found under the three links listed in Table 1 in its most current form. These links also contain additional examples of acceptable and unacceptable nomenclature. Continuously updated lists of assignments and correspondences approved in the context of these guidelines will be maintained on two WMDA-specified reference web sites: the IMGT/HLA database for HLA nomenclature (www.anthonynolan.org.uk/HIG/nomen/wmda.html) 15 and the US National Marrow Donor Program web site for codes that include multiple allele alternatives (bioinformatics. nmdp.org/HLA/allele_codes_idx.html) 8 ( Table 1 ). The latter site includes contact information for registry requests for 2.3. A maximum of two antigens can be provided for each locus and/or a maximum of two allele assignments can be provided for each locus. Exceptions are known to occur, but they are extremely rare. These exceptions may be noted in a remarks field. 2.4. If the identity of an antigen is unknown, further testing using a DNA-based method is recommended to clarify the assignment. The code X may not be used to indicate unclear serologic assignments. For example A2, A'X' will not be accepted. 2.5. If the typing suggests that a previously unknown allele is probably present, the result should be reported as the special code 'NEW'. Once the allele has been characterized and an allele assignment received from the WHO HLA Nomenclature Committee, the typing should be updated. 2.6. Corresponding antigen and allele assignments, if submitted together, must be consistent. Changes will be announced on the reference web sites and will become valid 48 h later. These guidelines will ensure that international unrelated donor searches proceed in a timely fashion and that issues of HLA nomenclature do not impede their progress. The guidelines will also assist registries and cord blood banks in designing their search algorithms to incorporate and compare all approved HLA assignments and will lead to more accurate searches. The WMDA working groups will continue to monitor the evolution of approaches, 16, 18 which may communicate more precisely the ambiguities arising in HLA typing than the current coding system to incorporate these approaches into WMDA guidelines where appropriate.
